Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV001808259 | SCV002058897 | likely pathogenic | CHARGE syndrome | 2022-01-03 | criteria provided, single submitter | clinical testing | Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_VS).It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Gene |
RCV002463038 | SCV002756917 | likely pathogenic | not provided | 2022-05-19 | criteria provided, single submitter | clinical testing | Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26921530, 22461308) |
Equipe Genetique des Anomalies du Developpement, |
RCV001808259 | SCV003920978 | pathogenic | CHARGE syndrome | 2023-03-23 | criteria provided, single submitter | clinical testing |